Merck KGaA Catalyst Calendar

Proactively evaluate Merck KGaA’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

A sample of Merck KGaA Catalyst Calendar data

Event Date Event Type Company Name Ticker Symbol Drug Name Therapy Area Indication Source Type
Showing 3 of 360+ results. Subscribe to unlock more.
13 Sep 2019 GDCTXXXX Lorem Lorem Lorem XXXX Planned Lorem
11 Sep 2019 Phase I Trial Completion Merck KGaA; PPD Inc MRK Novothyrox Hormonal Disorders; Oncology Goiter; Graves Diseases; Hashimoto Thyroiditis; Hypothyroidism; Thyroid Cancer; Thyroid Gland Disorders Clinical Trial Registry
02 Sep 2019 Phase I Trial Completion EMD Serono Research & Development Institute Inc; Merck KGaA MRK M-3541 Oncology Head And Neck Cancer; Solid Tumor Clinical Trial Registry
01 Sep 2019 Phase IV Trial Initiation Merck KGaA; University of Munster MRK cladribine Central Nervous System Multiple Sclerosis; Relapsing Multiple Sclerosis (RMS) Clinical Trial Registry
Catalyst Calendar


Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.



  • Trial Events for trials conducted globally by a company, university, institute or CRO:  Trial Initiation, Trial Completion, Trial Results
  • Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
  • Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)


Proactively evaluate companies and catalyst impacts

Stay ahead of the competition & improve corporate planning

Bolster business development with timely opportunities

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.


Access more premium companies when you subscribe to Explorer